14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ICSH vs NEAR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ICSH Captures Overall Composite Edge (57.9 HOLD vs 46.4 HOLD), While NEAR Leads 1–0 on Growth & Valuation Pillars
ICSH Overall Winner
6-Pillar Tally: ICSH 0 – 1 NEAR (5 Tie)
Matrix Metrics: ICSH 3 – 0 NEAR
As of Nov 16, 2026, iShares Ultra Short Duration Bond Active ETF (ICSH) captures the overall head-to-head institutional edge over iShares Short Duration Bond Active ETF (NEAR) on higher Unified Composite conviction (57.9/100 HOLD vs. 46.4/100 HOLD) after splitting the core matrix 3–0 (led by composite factor balance), while NEAR wins 1–0 across the 6-pillar growth and valuation breakdown. ICSH trades at $50.34 (N/M Forward P/E, N/A operating margin) versus NEAR at $49.84 (N/M Forward P/E, N/A operating margin).
Growth vs. Quality Trade-Off: ICSH earns the overall head-to-head edge with a stronger Unified Composite Score (57.9/100 HOLD vs. NEAR 46.4/100 HOLD) and 0.01β · 1% Vol risk profile, whereas NEAR leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: ICSH is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.4); meanwhile NEAR is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ICSH vs NEAR. Trailing 12-month operating profitability (ICSH N/A vs NEAR N/A) and valuation multiples (ICSH N/M vs NEAR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
NEAR Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ICSH vs NEAR Key Questions & Quantitative Answers
As of Nov 16, 2026, iShares Ultra Short Duration Bond Active ETF (ICSH) captures the overall head-to-head institutional edge over iShares Short Duration Bond Active ETF (NEAR) on higher Unified Composite conviction (57.9/100 HOLD vs. 46.4/100 HOLD) after splitting the core matrix 3–0 (led by composite factor balance), while NEAR wins 1–0 across the 6-pillar growth and valuation breakdown. ICSH trades at $50.34 (N/M Forward P/E, N/A operating margin) versus NEAR at $49.84 (N/M Forward P/E, N/A operating margin). Growth vs. Quality Trade-Off: ICSH earns the overall head-to-head edge with a stronger Unified Composite Score (57.9/100 HOLD vs. NEAR 46.4/100 HOLD) and 0.01β · 1% Vol risk profile, whereas NEAR leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: ICSH is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.4); meanwhile NEAR is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ICSH and NEAR split Growth & Scale metrics: ICSH posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with NEAR at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ICSH generates N/A in USD-normalized revenue versus N/A for NEAR. In operating R&D and SG&A reinvestment, ICSH deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NEAR.
ICSH and NEAR trade at balanced relative valuation multiples. ICSH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas NEAR trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ICSH (N/A ROE) versus NEAR (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, ICSH carries 52.6% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.01β · 1% Vol realized risk). By comparison, NEAR carries 20.8% implied volatility (39th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 2% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.